IDYA - IDEAYA Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5132M
Enterprise Value 380.24M
Trailing P/E N/A
Forward P/E 1-1.86
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.44
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.87

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 32.33%
52 Week High 316.90
52 Week Low 36.12
50-Day Moving Average 37.44
200-Day Moving Average 38.90

Share Statistics

Avg Vol (3 month) 373.7k
Avg Vol (10 day) 315.05k
Shares Outstanding 5N/A
Float 3.42M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Jul 31, 2019) 429.8k
Short Ratio (Jul 31, 2019) 41.09
Short % of Float (Jul 31, 2019) 40.22%
Short % of Shares Outstanding (Jul 31, 2019) 40.15%
Shares Short (prior month Jun 28, 2019) 4128.25k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -43.01M
Net Income Avi to Common (ttm)-41.84M
Diluted EPS (ttm)-14.66
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)120.16M
Total Cash Per Share (mrq)14.62
Total Debt (mrq)7.44M
Total Debt/Equity (mrq)6.17
Current Ratio (mrq)18.94
Book Value Per Share (mrq)14.68

Cash Flow Statement

Operating Cash Flow (ttm)-36.23M
Levered Free Cash Flow (ttm)N/A